We built our state of the art 30 bed facility with the security and comfort of our research participants in mind. This includes various amenities, such as an exercise area and an entertainment room with internet access. Our residents will enjoy nutritious and well-balanced meals provided by a local catering company.
Apart from these, we also provide free parking and free transportation for all our research participants.
We conduct all of our clinical studies in strict accordance with protocols reviewed by the FDA along with an Institutional Review Board representing public interest. For example, when conducting a memory loss test in St. Louis or other research studies, progress is closely monitored by each of these agencies. Participants are evaluated frequently throughout the course of the study to document effectiveness and safety of the medication. Test subjects may withdraw from the study at any time, or be withdrawn, should the investigator feel that it is in their best interest to do so.
Researchers spend an extensive amount of money and time looking for new methods in diagnosing and treating illnesses and diseases every year.
Before we approve any new medication, these medications undergo a series of lengthy and rigorous tests. Not only do medications have to be safe and effective, but they also must demonstrate a superior benefit when compared to other drugs that have similar effects. This strict adherence to quality makes St. Louis Clinical Trials the leading research agency on dementia and other memory conditions in the St. Louis area.
Subjects that participate in research may be compensated for time and travel.
Pacific Research Network (PRN) is a Southern California clinical research facility that specializes in examining new, investigational medications for the treatment of a variety of diseases.
With clinic locations in San Diego and Rancho Bernardo, Pacific Research Network has been a leader in the field of clinical research for over 35 years and is dedicated to providing quality research for both volunteers and the pharmaceutical industry.
Stephen G. Thein, PhD, the director and founder of Pacific Research Network, has conducted over 250 clinical trials and is one of the nation’s leading researchers in memory and Alzheimer’s disease. Dr. Thein has participated in the testing of several new medications to treat Alzheimer’s disease, memory loss, anxiety, migraine, sleep disorders, sexual dysfunction, smoking, social anxiety, and weight loss.